BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2442938)

  • 1. An in vitro human skin model for assaying topical drugs against dermatophytic fungi.
    Kligman AM; McGinley KJ; Foglia A
    Acta Derm Venereol; 1987; 67(3):243-8. PubMed ID: 2442938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mycological analysis valuable for evaluating therapeutic efficacy of antimycotics against experimental dermatophytosis in guinea pigs.
    Majima T; Masui S; Uchida K; Yamaguchi H
    Mycoses; 2005 Mar; 48(2):108-13. PubMed ID: 15743427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of terbinafine on Trichophyton mentagrophytes in a human living skin equivalent model.
    Rashid A; Edward M; Richardson MD
    J Med Vet Mycol; 1995; 33(4):229-33. PubMed ID: 8531020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model.
    Ghannoum MA; Long L; Pfister WR
    Mycoses; 2009 Jan; 52(1):35-43. PubMed ID: 18498299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation the antimycotic activity of itraconazole in human stratum corneum with vitro fungi cultivation].
    Xu W; Zhao JY; Wang L
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):530-3. PubMed ID: 15949332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
    Santos DA; Hamdan JS
    Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
    Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
    Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
    Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
    Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo activity and metabolic fate of 2-(2,3,3-triiodoallyl)tetrazole (ME1401), a novel antifungal agent.
    Fukuyasu H; Orikasa Y; Kai F; Inouye S; Kitasato I; Yamaguchi H
    Drugs Exp Clin Res; 1989; 15(8):335-47. PubMed ID: 2598775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloprogin: a topical antifungal agent.
    Harrison EF; Zwadyk P; Bequette RJ; Hamlow EE; Tavormina PA; Zygmunt WA
    Appl Microbiol; 1970 May; 19(5):746-50. PubMed ID: 5422306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungitoxic studies on bark extract of Lawsonia inermis against ringworm fungi.
    Singh VK; Pandey DK
    Hindustan Antibiot Bull; 1989; 31(1-2):32-5. PubMed ID: 2613539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species distribution and antifungal susceptibilities of dermatophytes during a one year period at a university hospital in Turkey.
    Ozkutuk A; Ergon C; Yulug N
    Mycoses; 2007 Mar; 50(2):125-9. PubMed ID: 17305776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Efficacy of ME1111 in the Topical Treatment of Dermatophytosis in a Guinea Pig Model.
    Long L; Hager C; Ghannoum M
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2343-5. PubMed ID: 26833160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the growth in vitro of Trichophyton mentagrophytes, Trichophyton erinacei and Microsporum persicolor by miconazole and chlorhexidine.
    Perrins N; Howell SA; Moore M; Bond R
    Vet Dermatol; 2005 Oct; 16(5):330-3. PubMed ID: 16238813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility of fungi isolated from clinical materials to voriconazole].
    Pawlik B; Szul A; Macura AB
    Med Dosw Mikrobiol; 2006; 58(2):155-61. PubMed ID: 17133909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effectiveness of 13 agents in otomycosis and review of the literature.
    Stern JC; Shah MK; Lucente FE
    Laryngoscope; 1988 Nov; 98(11):1173-7. PubMed ID: 3054372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes.
    Koroishi AM; Foss SR; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
    J Ethnopharmacol; 2008 May; 117(2):270-7. PubMed ID: 18394835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds?
    Flamand N; Marrot L; Belaidi JP; Bourouf L; Dourille E; Feltes M; Meunier JR
    Mutat Res; 2006 Jul; 606(1-2):39-51. PubMed ID: 16675293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity of the silver ion against contaminated fabric.
    Jung WK; Kim SH; Koo HC; Shin S; Kim JM; Park YK; Hwang SY; Yang H; Park YH
    Mycoses; 2007 Jul; 50(4):265-9. PubMed ID: 17576317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.